AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7654798 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (3-month supervised group exercise program)
Number of subjects: 42
Study 7654798 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 42
Study 2630378 — intervention group
Group type: EXPERIMENTAL
Intervention: self blood glucose monitoring, twice every other day
Number of subjects: 208
Study 2630378 — intervention group
Group type: EXPERIMENTAL
Intervention: self-urine glucose monitoring, twice every other day
Number of subjects: 208
Study 2630378 — intervention group
Group type: COMPARATOR
Intervention: regular HbA1c determinations but no self-monitoring
Number of subjects: 208
Study 798128 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa + G 31.406
Number of subjects: 60
Study 798128 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa + chl. amantadine
Number of subjects: 60
Study 798128 — intervention group
Group type: COMPARATOR
Intervention: L-dopa + placebo
Number of subjects: 60
Study 30626548 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral double suspension sutures (DSS)
Number of subjects: 0
Study 30626548 — intervention group
Group type: COMPARATOR
Intervention: Bilateral single palatal suspension sutures (SSS)
Number of subjects: 0
Study 28671093 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM pulmonary rehabilitation therapy
Number of subjects: 79
Study 28671093 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 79
Study 26073389 — intervention group
Group type: EXPERIMENTAL
Intervention: ERN-LRPT
Number of subjects: 11310
Study 26073389 — intervention group
Group type: EXPERIMENTAL
Intervention: ERN-NSP
Number of subjects: 11310
Study 26073389 — intervention group
Group type: COMPARATOR
Intervention: statin-PBO
Number of subjects: 11310
Study 24156136 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate (experimental)
Number of subjects: 446
Study 24156136 — intervention group
Group type: COMPARATOR
Intervention: 1450 ppm fluoride as sodium monofluorophosphate (positive control)
Number of subjects: 446
Study 24156136 — intervention group
Group type: COMPARATOR
Intervention: No fluoride (negative control)
Number of subjects: 446
Study 21540202 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for fatigue self-management, comprising six weekly 2-hour sessions and a consolidation session at week 14.
Number of subjects: 127
Study 21540202 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving fatigue self-management information in a 1-hour didactic group session.
Number of subjects: 127
Study 21540202 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for fatigue self-management.
Number of subjects: 127
Study 19042929 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic camera holding (Ro)
Number of subjects: 38
Study 19042929 — intervention group
Group type: COMPARATOR
Intervention: Human camera holding (Hu)
Number of subjects: 38
Study 16718764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecabet sodium (1.5 g twice a day)
Number of subjects: 272
Study 16718764 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (400 mg twice a day)
Number of subjects: 272
Study 14729239 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of diazepam
Number of subjects: 0
Study 14729239 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study 12296675 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff pressure adjusted to 20 mm Hg
Number of subjects: 51
Study 12296675 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjustment of ETCP)
Number of subjects: 51
Study 9694180 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in a patient‐centred intervention for GPs and practice nurses
Number of subjects: 252
Study 9694180 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 252
Study 7806810 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinel's sign
Number of subjects: 32
Study 7806810 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbow flexion test
Number of subjects: 32
Study 7806810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure provocation test
Number of subjects: 32
Study 7806810 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined elbow flexion and pressure provocation test
Number of subjects: 32
Study 2649864 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant treatment
Number of subjects: 61
Study 15467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fazadinium 1 mg/kg
Number of subjects: 0
Study 15467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fazadinium 1-25 mg/kg
Number of subjects: 0
Study 15467 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg
Number of subjects: 0
Study 15467 — intervention group
Group type: COMPARATOR
Intervention: Alcuronium 0-32 mg/kg
Number of subjects: 0
Study 30871544 — intervention group
Group type: EXPERIMENTAL
Intervention: iFightDepression® tool
Number of subjects: 360
Study 30871544 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (control condition)
Number of subjects: 360
Study 28894017 — intervention group
Group type: EXPERIMENTAL
Intervention: Early integrated palliative care (PC)
Number of subjects: 275
Study 28894017 — intervention group
Group type: COMPARATOR
Intervention: Oncology care alone
Number of subjects: 275
Study 25312518 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema-Based Instruction (SBI)
Number of subjects: 260
Study 25312518 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 260
Study 25555887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 7 days
Number of subjects: 516
Study 25555887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 28 days
Number of subjects: 516
Study 25555887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone treatment for 4 weeks followed by dose tapering over 7 or 28 days
Number of subjects: 516
Study 21975470 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic back muscle exercise (Group B)
Number of subjects: 60
Study 21975470 — intervention group
Group type: COMPARATOR
Intervention: General postoperation therapy (Group A)
Number of subjects: 60
Study 19875311 — intervention group
Group type: EXPERIMENTAL
Intervention: GS=1 (single items, i.e., 12 x 1 item)
Number of subjects: 126
Study 19875311 — intervention group
Group type: EXPERIMENTAL
Intervention: GS=3 (4 x 3 items)
Number of subjects: 126
Study 19875311 — intervention group
Group type: EXPERIMENTAL
Intervention: GS=6 (2 x 6 items)
Number of subjects: 126
Study 19875311 — intervention group
Group type: EXPERIMENTAL
Intervention: GS=12 (standard presentation mode, i.e., 1 x 12 items)
Number of subjects: 126
Study 19875311 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal grouping and grouped overt rehearsal
Number of subjects: 126
Study 17873305 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel (30 mg/m2), epirubicin (30 mg/m2), and carboplatin (AUC 2) with filgrastim support
Number of subjects: 72
Study 15625814 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide through Nebuchamber
Number of subjects: 69
Study 15625814 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate through Babyhaler
Number of subjects: 69
Study 15625814 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuchamber
Number of subjects: 69
Study 11518846 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment withdrawal (group A1)
Number of subjects: 20
Study 11518846 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment withdrawal (group A2)
Number of subjects: 20
Study 11518846 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group B)
Number of subjects: 20
Study 9220100 — intervention group
Group type: EXPERIMENTAL
Intervention: Allen test performed by four physician examiners
Number of subjects: 200
Study 8240556 — intervention group
Group type: EXPERIMENTAL
Intervention: Actidose Aqua AC (1,500 m2/g)
Number of subjects: 5
Study 8240556 — intervention group
Group type: EXPERIMENTAL
Intervention: Norit A Supra AC (2,000 m2/g)
Number of subjects: 5
Study 8240556 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no AC administered)
Number of subjects: 5
Study 2822337 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone
Number of subjects: 40
Study 2822337 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 40
Study 29357358 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention programme (cognitive therapy, relaxation therapy, emotional support)
Number of subjects: 60
Study 29357358 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychological intervention)
Number of subjects: 60
Study 27624471 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg ferroquine
Number of subjects: 8
Study 23954043 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of health marks and traffic light colour-coding
Number of subjects: 160
Study 23954043 — intervention group
Group type: COMPARATOR
Intervention: Health marks only
Number of subjects: 160
Study 23954043 — intervention group
Group type: COMPARATOR
Intervention: Traffic light colours only
Number of subjects: 160
Study 22134388 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine with Irbesartan
Number of subjects: 160
Study 22134388 — intervention group
Group type: COMPARATOR
Intervention: Felodipine with Metoprolol
Number of subjects: 160
Study 21029646 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery variation (variant group)
Number of subjects: 280
Study 21029646 — intervention group
Group type: COMPARATOR
Intervention: Usual coronary arteries (usual group)
Number of subjects: 280
Study 18772303 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 27
Study 18772303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 15903387 — intervention group
Group type: EXPERIMENTAL
Intervention: WL
Number of subjects: 32
Study 15903387 — intervention group
Group type: EXPERIMENTAL
Intervention: VJ
Number of subjects: 32
Study 15903387 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 14755115 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation I of ramipril (5 mg)
Number of subjects: 36
Study 14755115 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation II of ramipril (5 mg)
Number of subjects: 36
Study 14755115 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of ramipril (5 mg)
Number of subjects: 36
Study 10864982 — intervention group
Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 600 microg and PO dexamethasone at 8 mg
Number of subjects: 5
Study 10864982 — intervention group
Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg and PO dexamethasone at 8 mg
Number of subjects: 5
Study 10864982 — intervention group
Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg and PO dexamethasone at 12 mg
Number of subjects: 5
Study 10864982 — intervention group
Group type: EXPERIMENTAL
Intervention: SC G‐CSF at 450 microg
Number of subjects: 5
Study 10864982 — intervention group
Group type: EXPERIMENTAL
Intervention: PO dexamethasone at 12 mg
Number of subjects: 5
Study 8900983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross‐coupled rotation with varying gyroscopic angular acceleration
Number of subjects: 0
Study 8900983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross‐coupled rotation with or without restriction of head movement
Number of subjects: 0
Study 1412655 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (high doses)
Number of subjects: 0
Study 4015937 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethiazole infusion 10 ml min‐1 over 16 (+/‐ 6) min
Number of subjects: 21
Study 4015937 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam loading dose of 20 (+/‐ 15) mg at a rate of 1 mg min‐1
Number of subjects: 21
Study 30206618 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol-enriched beverage (2 g of PS added)
Number of subjects: 38
Study 27690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab every other week (300 mg)
Number of subjects: 1379
Study 27690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab weekly (300 mg)
Number of subjects: 1379
Study 27690741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379
Study 27690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 1379
Study 25311083 — intervention group
Group type: EXPERIMENTAL
Intervention: Late Eating (LE; lunch at 16:30)
Number of subjects: 32
Study 24094791 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training (n=15)
Number of subjects: 31
Study 24094791 — intervention group
Group type: COMPARATOR
Intervention: Placebo/control (n=16)
Number of subjects: 31
Study 19926594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led multidisciplinary intervention
Number of subjects: 750
Study 19926594 — intervention group
Group type: COMPARATOR
Intervention: Usual post-discharge care
Number of subjects: 750
Study 18257045 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-ROM-based educational intervention on anticoagulation guidelines
Number of subjects: 117
Study 18257045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CD-ROM intervention)
Number of subjects: 117
Study 18257045 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-ROM-based educational intervention
Number of subjects: 117
Study 16616348 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 42
Study 16616348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 14668709 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 0
Study 14668709 — intervention group
Group type: COMPARATOR
Intervention: Low-osmolar agents
Number of subjects: 0
Study 10999872 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg and dry powder budesonide 100 microg twice daily
Number of subjects: 27
Study 10999872 — intervention group
Group type: COMPARATOR
Intervention: Placebo and dry powder budesonide 200 microg twice daily
Number of subjects: 27
Study 8771064 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) injection around one eye
Number of subjects: 6
Study 8771064 — intervention group
Group type: COMPARATOR
Intervention: Saline solution injection around the other eye (Control)
Number of subjects: 6
Study 1466596 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Health Assessment Questionnaire (MHAQ)
Number of subjects: 100
Study 1466596 — intervention group
Group type: COMPARATOR
Intervention: Health Assessment Questionnaire (HAQ)
Number of subjects: 100
Study 6366150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) regimen
Number of subjects: 38
Study 6366150 — intervention group
Group type: COMPARATOR
Intervention: Regular follow-up without primary adjuvant chemotherapy
Number of subjects: 38
Study 31509202 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First Intervention with Intensive Case Management
Number of subjects: 31
Study 31509202 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 31
Study 29108530 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach-avoidance training (AAT) for food cues
Number of subjects: 59
Study 27302673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic school meals
Number of subjects: 834
Study 27302673 — intervention group
Group type: COMPARATOR
Intervention: Packed lunch from home (control)
Number of subjects: 834
Study 27129008 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel 1%
Number of subjects: 11
Study 27129008 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel 2%
Number of subjects: 11
Study 27129008 — intervention group
Group type: COMPARATOR
Intervention: Testogel
Number of subjects: 11
Study 22834852 — intervention group
Group type: EXPERIMENTAL
Intervention: MOMS program (eight structured classes starting in the first trimester of pregnancy, occurring every other week until the third trimester)
Number of subjects: 65
Study 22834852 — intervention group
Group type: EXPERIMENTAL
Intervention: MOMS program
Number of subjects: 65
Study 22834852 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care (control group)
Number of subjects: 65
Study 21054291 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-of-processing training
Number of subjects: 908
Study 21054291 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 908
Study 21054291 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 908
Study 21054291 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 908
Study 17652452 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual 400 microg misoprostol and 100 mg diclofenac
Number of subjects: 80
Study 17652452 — intervention group
Group type: COMPARATOR
Intervention: 100 mg diclofenac alone (control group)
Number of subjects: 80
Study 15977880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intacs inserts
Number of subjects: 37
Study 12148189 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/3 patellar tendon graft (B‐T‐B) with sutures on screws or staples, 4-5 week immobilisation post-op
Number of subjects: 38
Study 12148189 — intervention group
Group type: COMPARATOR
Intervention: Graft fixation with interferential screws, no post-op immobilisation
Number of subjects: 38
Study 9917447 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotaped STD risk assessment and education about staying safe (safer = condoms, safest = abstinence)
Number of subjects: 215
Study 9917447 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 215
Study 7478826 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-PUFA-supplemented formula
Number of subjects: 90
Study 7478826 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula
Number of subjects: 90
Study 7478826 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed exclusively
Number of subjects: 90
Study 1832359 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1
Number of subjects: 1030
Study 1832359 — intervention group
Group type: COMPARATOR
Intervention: Fructosamine
Number of subjects: 1030
Study 6308996 — intervention group
Group type: EXPERIMENTAL
Intervention: Locust bean gum (LBG) food products (8 to 30 g/day)
Number of subjects: 38
Study 6308996 — intervention group
Group type: COMPARATOR
Intervention: Control feeding periods (without LBG)
Number of subjects: 38
Study 30454724 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically closed VSD
Number of subjects: 96
Study 30454724 — intervention group
Group type: COMPARATOR
Intervention: Unrepaired VSD
Number of subjects: 96
Study 30454724 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 96
Study 30615489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling vest during exercise
Number of subjects: 10
Study 30615489 — intervention group
Group type: COMPARATOR
Intervention: No cooling vest during exercise
Number of subjects: 10
Study 26562708 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (20 g)
Number of subjects: 9
Study 26562708 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 g corn starch maltodextrin)
Number of subjects: 9
Study 24490871 — intervention group
Group type: EXPERIMENTAL
Intervention: StepUp program (6-week pedometer-based self-management program)
Number of subjects: 70
Study 24490871 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study 21733988 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program (twice a week for 8 weeks)
Number of subjects: 90
Study 19691996 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (PP group)
Number of subjects: 763
Study 19691996 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 763
Study 17089153 — intervention group
Group type: COMPARATOR
Intervention: Exercise training (ET; n = 7, 40 min session(‐1), five times per week at 60% VO2max)
Number of subjects: 28
Study 17089153 — intervention group
Group type: COMPARATOR
Intervention: Carnitine supplementation (CS; n = 7, 4 g day(‐1))
Number of subjects: 28
Study 17089153 — intervention group
Group type: COMPARATOR
Intervention: Exercise training and carnitine supplementation (CT; n = 7)
Number of subjects: 28
Study 17089153 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON; n = 7)
Number of subjects: 28
Study 15868619 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized nailfold video capillaroscopy system
Number of subjects: 120
Study 15868619 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects + primary RP patients)
Number of subjects: 120
Study 12215207 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine plus zidovudine (AZT) and didanosine (DDI)
Number of subjects: 20
Study 12215207 — intervention group
Group type: COMPARATOR
Intervention: zidovudine (AZT) and didanosine (DDI) without L-carnitine
Number of subjects: 20
Study 10786501 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (5 sessions, 12.4 minutes each)
Number of subjects: 27
Study 10786501 — intervention group
Group type: COMPARATOR
Intervention: Simple presence (5 sessions, 10.3 minutes each)
Number of subjects: 27
Study 7876438 — intervention group
Group type: EXPERIMENTAL
Intervention: Notched-noise maskers (NN) and narrow-band maskers (NB) in a background of spectrally shaped broadband noise (SSBB)
Number of subjects: 0
Study 7876438 — intervention group
Group type: EXPERIMENTAL
Intervention: Consonant recognition in SSBB
Number of subjects: 0
Study 7876438 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-masker conditions using a modified power-law model of masking additivity
Number of subjects: 0
Study 1972375 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral infusion programs with varying carbohydrate and lipid content (up to 40% of total caloric content)
Number of subjects: 32
Study 1972375 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid solutions used as an energy source in early postoperative period
Number of subjects: 32